2018
DOI: 10.1161/jaha.117.007332
|View full text |Cite
|
Sign up to set email alerts
|

Frequency of Care and Mortality Following an Incident Diagnosis of Peripheral Artery Disease in the Inpatient or Outpatient Setting: The ARIC (Atherosclerosis Risk in Communities) Study

Abstract: BackgroundAvailable health services data for individuals with peripheral artery disease (PAD) are often from studies of those eligible for or undergoing intervention. Knowledge of the frequency of care and mortality following an initial PAD diagnosis by setting (outpatient versus inpatient) is limited and represents an opportunity to provide new benchmark information.Methods and ResultsThe purpose of this study was to characterize the frequency of care and mortality following an incident PAD diagnosis in the o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 39 publications
0
15
0
Order By: Relevance
“…Peripheral artery disease has a well-established high risk of death following diagnosis ( 34 ). Death rates are particularly high among patients diagnosed with PAD in the inpatient setting ( 35 ). Less is known about the racial/ethnic pattern of in-hospital mortality among PAD patients, particularly in patients that are not Black or White.…”
Section: Discussionmentioning
confidence: 99%
“…Peripheral artery disease has a well-established high risk of death following diagnosis ( 34 ). Death rates are particularly high among patients diagnosed with PAD in the inpatient setting ( 35 ). Less is known about the racial/ethnic pattern of in-hospital mortality among PAD patients, particularly in patients that are not Black or White.…”
Section: Discussionmentioning
confidence: 99%
“…Further, PROMs will be needed when treatments are compared across different groups in clinical trials. [20][21][22][23] Finally, the overall impact of systematic treatment of the comorbidities which often occurs concomitantly with CLTI, such as diabetes and smoking, may have small impact at the individual level. However, when examining small changes in QoL using accurate tools, differences may be detectable in large populations if the measures are precise and reproducible.…”
Section: How Stakeholders Can Work To Advance Proms In Cltimentioning
confidence: 99%
“…The finding that low socioeconomic status was associated with increased risk of MACE in PAD patients was consistent with prior studies. Disadvantaged individuals, such as non-white or low-income patients (e.g., Medicaid recipients) have been reported to experience more metabolic comorbidities that aggravated PAD than the socioeconomically advantaged population [ 25 ]. The development of cardiovascular events is also known to be related to some social determinants of health (e.g., income).…”
Section: Discussionmentioning
confidence: 99%